Publication:
Temporal trends in the epidemiology of HIV in Turkey

dc.contributor.buuauthorHeper, Yasemin
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentEnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
dc.contributor.researcheridAAH-6506-2021
dc.contributor.scopusid56191003300
dc.date.accessioned2024-02-07T07:29:23Z
dc.date.available2024-02-07T07:29:23Z
dc.date.issued2020
dc.descriptionÇalışmada 28 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır.
dc.description.abstractObjective: The aim of this study was to analyze the temporal trends of HIV epidemiology in Turkey from 2011 to 2016. Methods: Thirty-four teams from 28 centers at 17 different cities participated in this retrospective study. Participating centers were asked to complete a structured form containing questions about epidemiologic, demographic and clinical characteristics of patients presented with new HIV diagnosis between 2011 and 2016. Demographic data from all centers (complete or partial) were included in the analyses. For the cascade of care analysis, 15 centers that provided full data from 2011 to 2016 were included. Overall and an-nual distributions of the data were calculated as percentages and the Chi square test was used to determine temporal changes. Results: A total of 2,953 patients between 2011 and 2016 were included. Overall male to female ratio was 5:1 with a significant increase in the number of male cases from 2011 to 2016 (p<0.001). The highest prevalence was among those aged 25-34 years followed by the 35-44 age bracket. The most common rea-son for HIV testing was illness (35%). While the frequency of sex among men who have sex with men increased from 16% to 30.6% (p[removed]500 cells/mm3 while 46.7% presented with a CD4 T cell count of <350 cells/mm3. Among newly diagnosed cases, 79% were retained in care, and all such cases initiated ART with 73% achieving viral suppression after six months of antiretroviral therapy. Conclusion: The epidemiologic profile of HIV infected individuals is changing rapidly in Turkey with an increasing trend in the number of newly diagnosed people disclosing themselves as MSM. New diagnoses were mostly at a young age. The late diagnosis was found to be a challenging issue. Despite the unavailability of data for the first 90, Turkey is close to the last two steps of 90-90-90 targets.
dc.identifier.citationErdinç, F. S. vd. (2020). "Temporal trends in the epidemiology of HIV in Turkey". Current HIV Research, 18(4), 258-266.
dc.identifier.doihttps://doi.org/10.2174/1570162X18666200427223823
dc.identifier.endpage266
dc.identifier.issn1570162X
dc.identifier.issn1873-4251
dc.identifier.issue4
dc.identifier.pubmed32342820
dc.identifier.scopus2-s2.0-85089702274
dc.identifier.startpage258
dc.identifier.urihttps://www.eurekaselect.com/article/106175
dc.identifier.urihttps://hdl.handle.net/11452/39579
dc.identifier.volume18
dc.identifier.wos000567603000004
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherBentham Science Publisher
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalCurrent HIV Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHIV
dc.subjectAIDS
dc.subjectEpidemiology
dc.subjectCo-infection
dc.subjectDiagnosis
dc.subjectFatality
dc.subjectHBV
dc.subjectHCV
dc.subjectImmunology
dc.subjectInfectious
dc.subjectDiseases
dc.subjectVirology
dc.subjectAntiretroviral therapy
dc.subjectHIV/AIDS patients
dc.subjectHepatitis-bprevalence
dc.subjectSex
dc.subjectMen
dc.subjectInitiation
dc.subjectInfection
dc.subjectVirüs
dc.subjectCoinfection
dc.subject.emtreeAnti human immunodeficiency virus agent
dc.subject.emtreeAdult
dc.subject.emtreeAntiretroviral therapy
dc.subject.emtreeArticle
dc.subject.emtreeCD4 lymphocyte count
dc.subject.emtreeCD4+ T lymphocyte
dc.subject.emtreeDeath
dc.subject.emtreeFemale
dc.subject.emtreeHepatitis B virus
dc.subject.emtreeHepatitis C virus
dc.subject.emtreeHuman
dc.subject.emtreeHuman immunodeficiency virus
dc.subject.emtreeHuman immunodeficiency virus infection
dc.subject.emtreeInjection drug user
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMiddle aged
dc.subject.emtreeMixed infection
dc.subject.emtreePregnancy
dc.subject.emtreePrevalence
dc.subject.emtreeProspective study
dc.subject.emtreeRetrospective study
dc.subject.emtreeRisk factor
dc.subject.emtreeSeroconversion
dc.subject.emtreeSexual intercourse
dc.subject.emtreeSexual transmission
dc.subject.emtreeSmoking
dc.subject.emtreeSyphilis
dc.subject.emtreeTrend study
dc.subject.emtreeTuberculosis
dc.subject.emtreeTurkey (republic)
dc.subject.emtreeVenereal disease reaction test
dc.subject.emtreeAdolescent
dc.subject.emtreeChild
dc.subject.emtreeClinical trial
dc.subject.emtreeCoinfection
dc.subject.emtreeDelayed diagnosis
dc.subject.emtreeDrug effect
dc.subject.emtreeHepacivirus
dc.subject.emtreeHepatitis B
dc.subject.emtreeHepatitis C
dc.subject.emtreeHeterosexuality
dc.subject.emtreeHighly active antiretroviral therapy
dc.subject.emtreeHuman immunodeficiency virus infection
dc.subject.emtreeIncidence
dc.subject.emtreeInfant
dc.subject.emtreeMale homosexuality
dc.subject.emtreeMortality
dc.subject.emtreeMulticenter study
dc.subject.emtreePathogenicity
dc.subject.emtreePhysiology
dc.subject.emtreePreschool child
dc.subject.emtreeSurvival analysis
dc.subject.emtreeTurkey (bird)
dc.subject.emtreeVirology
dc.subject.emtreeVirus load
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAnti-HIV agents
dc.subject.meshAntiretroviral therapy, highly active
dc.subject.meshCD4 Lymphocyte Count
dc.subject.meshCD4-Positive T-Lymphocytes
dc.subject.meshChild
dc.subject.meshChild, preschool
dc.subject.meshCoinfection
dc.subject.meshDelayed diagnosis
dc.subject.meshFemale
dc.subject.meshHepacivirus
dc.subject.meshHepatitis B
dc.subject.meshHepatitis B virus
dc.subject.meshHepatitis C
dc.subject.meshHeterosexuality
dc.subject.meshHIV
dc.subject.meshHIV Infections
dc.subject.meshHomosexuality, male
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshInfant
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshRetrospective studies
dc.subject.meshSurvival analysis
dc.subject.meshTurkey
dc.subject.meshViral load
dc.subject.scopusHIV Testing; Human Immunodeficiency Virus 1; Marginal Structural Models
dc.subject.wosImmunology
dc.subject.wosInfectious Diseases
dc.subject.wosVirology
dc.titleTemporal trends in the epidemiology of HIV in Turkey
dc.typeArticle
dc.wos.quartileQ14
dc.wos.quartileQ1
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: